UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_______________ to______________ Commission file number: 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of registrant as specified in its charter) Montana 81-0305822 ( ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 Or 15(d) Of The Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 ☐ Transition Report Under Section 13 Or 15(d) Of The Securities Exchange Act of 1934 For the transition period ________ to ________ COMMISSION FILE NUMBER 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of small business issuer as specified in its charter) (State or oth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 Or 15(d) Of The Securities Exchange Act of 1934 For the quarterly period ended June 30, 2022 ☐ Transition Report Under Section 13 Or 15(d) Of The Securities Exchange Act of 1934 For the transition period ________ to ________ COMMISSION FILE NUMBER 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of small business issuer as specified in its charter) Montana 81-0305822 ...

[PART I - FINANCIAL INFORMATION](index=2&type=section&id=PART%20I%20-%20FINANCIAL%20INFORMATION) [Financial Statements](index=2&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS) The unaudited condensed consolidated financial statements for Q1 2022 report a **net income of $786,252**, a significant turnaround from a **$335,488** net loss in Q1 2021, primarily driven by substantial revenue growth Condensed Consolidated Balance Sheet Highlights (Unaudited) | | March 31, 2022 ($) | December 31, 2021 ($) | | :--- | :--- | :--- | | **Total Current Assets** | $24,096,396 | $23,568,992 | | **Total Assets** | $35,539,545 | $35,002,727 | | **Total Current Liabilities** | $1,744,678 | $2,020,855 | | **Total Liabilities** | $2,384,490 | $2,633,924 | | **Total Stockholders' Equity** | $33,155,055 | $32,368,803 | Condensed Consolidated Statements of Operations (Unaudited) | | Three months ended March 31, 2022 ($) | Three months ended March 31, 2021 ($) | | :--- | :--- | :--- | | **Revenue** | $3,580,306 | $1,253,287 | | **Gross Profit** | $1,139,388 | $212,157 | | **Income (Loss) from Operations** | $779,580 | $(341,726) | | **Net Income (Loss)** | $786,252 | $(335,488) | | **Net Income (Loss) per Share (Basic & Diluted)** | $0.01 | Nil | Condensed Consolidated Statements of Cash Flows Highlights (Unaudited) | | Three months ended March 31, 2022 ($) | Three months ended March 31, 2021 ($) | | :--- | :--- | :--- | | **Net cash provided (used) by operating activities** | $163,903 | $(2,449,854) | | **Net cash used by investing activities** | $(188,541) | $(23,298) | | **Net cash provided (used) by financing activities** | $(4,057) | $24,850,380 | [Note 1: Nature of Operations](index=5&type=section&id=NOTE%201%20-%20NATURE%20OF%20OPERATIONS) The company's core business involves producing antimony products, zeolite, and recovering precious metals, with operations spanning the US and Mexico - The company's primary business is producing and selling antimony products, relying on foreign sources since suspending its own mining in 1983, while developing properties in Mexico[12](index=12&type=chunk) - The company operates a zeolite business in Idaho, producing minerals for soil amendment, water filtration, and other industrial and agricultural applications[13](index=13&type=chunk)[17](index=17&type=chunk) - Wholly-owned subsidiaries in Mexico, Antimonio de Mexico S.A. de C.V. and United States Antimony, Mexico S.A. de C.V., focus on antimony exploration and development[14](index=14&type=chunk) [Note 4: Revenue Recognition](index=6&type=section&id=NOTE%204%20%E2%80%93%20REVENUE%20RECOGNITION) Total revenue for Q1 2022 reached **$3.58 million**, a significant increase from **$1.25 million** in Q1 2021, primarily driven by a surge in antimony sales Sales of Products (for the three months ended March 31) | Product | 2022 ($) | 2021 ($) | | :--- | :--- | :--- | | Antimony | $2,828,930 | $657,107 | | Zeolite | $674,042 | $519,947 | | Precious metals | $77,334 | $76,233 | | **Total Revenue** | **$3,580,306** | **$1,253,287** | [Note 11: Business Segments](index=9&type=section&id=NOTE%2011%20%E2%80%93%20BUSINESS%20SEGEMENTS) The company operates four segments, with U.S. Antimony being the primary driver of **$1.4 million** in Q1 2022 operational income, while Mexican Antimony reported a **$0.68 million** loss Income (Loss) from Operations by Segment (Q1 2022 vs Q1 2021) | Segment | Q1 2022 Income (Loss) ($) | Q1 2021 Income (Loss) ($) | | :--- | :--- | :--- | | Antimony - USA | $1,391,512 | $(218,669) | | Antimony - Mexico | $(684,037) | $(238,568) | | **Total Antimony** | **$707,475** | **$(457,237)** | | Precious Metals | $49,814 | $48,630 | | Zeolite | $22,291 | $66,881 | Total Assets by Segment | Segment | March 31, 2022 ($) | December 31, 2021 ($) | | :--- | :--- | :--- | | Antimony (US & Mexico) | $32,324,153 | $31,901,863 | | Precious Metals (US & Mexico) | $871,177 | $890,318 | | Zeolite | $2,344,215 | $2,210,546 | | **Total** | **$35,539,545** | **$35,002,727** | [Management's Discussion and Analysis and Plan of Operation](index=11&type=section&id=ITEM%202.%20MANAGEMENT%27S%20DISCUSSION%20AND%20ANALYSIS%20AND%20PLAN%20OF%20OPERATION.) Management attributes the significant Q1 2022 financial turnaround to the antimony segment's increased sales price and volume, with plans to use 2021 funds for operational improvements and production increases [Operational and Financial Performance](index=14&type=section&id=Operational%20and%20financial%20performance) Q1 2022 financial performance dramatically improved with **186% revenue growth to $3.58 million** and gross profit reaching **$1.14 million**, primarily driven by increased antimony sales prices and volumes Antimony Operational Metrics (Q1 2022 vs Q1 2021) | Antimony – combined USA and Mexico | 2022 | 2021 | | :--- | :--- | :--- | | Total revenue - antimony ($) | $2,828,930 | $657,107 | | Total pounds of antimony sold (pounds) | 433,350 | 181,969 | | Average sales price per pound ($/pound) | $6.53 | $3.61 | | Average gross profit per pound ($/pound) | $2.44 | $0.48 | Zeolite Operational Metrics (Q1 2022 vs Q1 2021) | Zeolite | 2022 | 2021 | | :--- | :--- | :--- | | Total revenue – zeolite ($) | $674,042 | $519,947 | | Total tons of zeolite sold (tons) | 3,026 | 2,743 | | Average sales price per ton ($/ton) | $222.75 | $189.55 | | Average gross profit per ton ($/ton) | $11.17 | $27.73 | - The company successfully modified and tested two new furnaces for antimony trisulfide production and ordered two additional furnaces to meet anticipated demand[78](index=78&type=chunk)[79](index=79&type=chunk) [EBITDA (Non-GAAP Measure)](index=15&type=section&id=EARNINGS%20BEFORE%20INTEREST%20TAX%20DEPRECIATION%20AND%20AMORTIZATION) Company-wide EBITDA for Q1 2022 significantly improved to **$1,009,384** from a negative **$(110,769)** in Q1 2021, primarily driven by the antimony segment's contribution of **$865,055** Company-wide EBITDA (Q1 2022 vs Q1 2021) | | March 31, 2022 ($) | March 31, 2021 ($) | | :--- | :--- | :--- | | Net Income (Loss) | $786,252 | $(335,488) | | Interest Expense | $2,983 | $2,255 | | Depreciation and Amortization | $220,150 | $222,464 | | **EBITDA** | **$1,009,384** | **$(110,769)** | [Liquidity and Financial Condition](index=16&type=section&id=LIQUIDITY%20AND%20FINANCIAL%20CONDITION) As of March 31, 2022, the company maintained a strong liquidity position with **$21.3 million** in cash and **$22.4 million** in working capital, with positive cash flow from operations of **$163,903** Working Capital | | March 31, 2022 ($) | December 31, 2021 ($) | | :--- | :--- | :--- | | Current assets | $24,096,396 | $23,568,992 | | Current liabilities | $(1,744,678) | $(2,020,855) | | **Working capital** | **$22,351,718** | **$21,548,137** | - As of March 31, 2022, the Company had cash on hand of **$21,334,353**[89](index=89&type=chunk) - The company plans to use funds from two 2021 stock offerings for significant improvements to its Madero, Puerto Blanco, Bear River Zeolite, and Thompson Falls facilities during 2022[90](index=90&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=17&type=section&id=ITEM%203.%20QUANTITATIVE%20AND%20QUALITATIVE%20DISCLOSURES%20ABOUT%20MARKET%20RISK) The company does not hold any derivative instruments or engage in hedging activities to manage market risk - The Company does not hold any derivative instruments or engage in any hedging activities[93](index=93&type=chunk) [Controls and Procedures](index=17&type=section&id=ITEM%204.%20CONTROLS%20AND%20PROCEDURES) Management concluded that the company's disclosure controls and procedures were not effective as of March 31, 2022, due to material weaknesses stemming from limited accounting staff and inadequate segregation of duties - Management concluded that the Company's disclosure controls and procedures were not effective due to material weaknesses[94](index=94&type=chunk) - Material weaknesses are attributed to the small accounting staff, limiting adequate segregation of duties, which the company mitigates through direct management oversight and external professionals[95](index=95&type=chunk) - No material changes occurred in the Company's internal controls over financial reporting during the quarter[96](index=96&type=chunk) [PART II - OTHER INFORMATION](index=17&type=section&id=PART%20II%20-%20OTHER%20INFORMATION) [Legal Proceedings](index=17&type=section&id=ITEM%201.%20LEGAL%20PROCEEDINGS.) The company is not a party to any material legal proceedings, nor is management aware of any threatened or contemplated actions - United States Antimony Corporation is not a party to any material legal proceedings[98](index=98&type=chunk) [Risk Factors](index=17&type=section&id=ITEM%201A.RISK%20FACTORS.) No material changes have occurred to the risk factors previously disclosed in the company's Form 10-K for the year ended December 31, 2021 - No material changes have occurred from the risk factors previously disclosed in the Company's Form 10-K for the year ended December 31, 2021[99](index=99&type=chunk) [Recent Sales of Unregistered Securities](index=17&type=section&id=ITEM%202.%20RECENT%20SALES%20OF%20UNREGISTERED%20SECURITIES.) The company did not sell or repurchase any common stock during the three months ended March 31, 2022 - For the three months ended March 31, 2022, the Company sold no common stock[100](index=100&type=chunk) [Mine Safety Disclosures](index=17&type=section&id=ITEM%204.%20MINE%20SAFETY%20DISCOSURES.) Information regarding mine safety violations, citations, and related matters is provided in Exhibit 95 to this quarterly report, in accordance with the Dodd-Frank Act - Information concerning mine safety violations required by Section 1503(a) of the Dodd-Frank Act is included in Exhibit 95 to this report[102](index=102&type=chunk) [Exhibits](index=18&type=section&id=ITEM%206.%20EXHIBITS.) This section lists the exhibits filed with the Form 10-Q, including officer certifications, mine safety disclosure, and Inline XBRL data files - The report includes exhibits for officer certifications, mine safety disclosure, and XBRL data files[103](index=103&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_______________ to______________ Commission file number: 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of registrant as specified in its charter) (State or other juri ...

For the quarterly period ended September 30, 2021 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of Registrant as specified in its charter) | Montana 81-0305822 | | | | - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File No. 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of Registrant as specified in its charter) Montana 8 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Montana 81-0305822 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) P.O. Box 643, Thompson Falls, Montana (Address of principal executive offices) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR Commission File No. 001-08675 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of registrant as specified in its charter) Montana 81-0305822 (State or other jurisdiction o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-08675 UNITED STATES ANTIMONY CORPORATION (Exact name of Registrant as specified in its charter) Montana 81-0305822 (State or o ...